Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities |
Research
Anticonvulsant Screening
Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
(TBI) Research
Technology Transfer
Office
NINDS is part of the
National Institutes of
Health
![]() |
Neurobiology of Persistent Pain Mediated by the Trigeminal Nerve
Release Date: September 16, 2003
Announcement Number: PA-03-173
Application Receipt Date:
October 1, 2003
February 1, 2004
June 1, 2004
October 1, 2004
February 1, 2005
June 1, 2005
October 1, 2005
June 1, 2006
Funding Contact: Linda Porter, Ph.D.
Program Area: Systems and Cognitive Neuroscience
Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS), along with the National Institute of Dental and Craniofacial
Research (NIDCR), invite applications to advance our understanding of the neurobiology of persistent pain mediated by the
trigeminal nerve and to develop effective therapeutic strategies to alleviate pain associated with disorders of myofascial,
nervous, or skeletal tissues of the head and face, which are innervated by this nerve. The purpose of this initiative is
to foster research that addresses the mechanisms of pain onset, chronic pain conditions, and responsiveness to pain therapy
through novel basic and clinical research. Current knowledge of the neurobiology and neurochemistry of nociception, pain
modulation and pain perception needs to be further developed and correlated with clinical manifestations of craniofacial
pain to improve therapeutic strategies. This Program Announcement with Set-Aside funds (PAS) contributes to the goals of
the NIH Pain Consortium, which is co- chaired by NINDS, NIDCR, and the National Institute of Nursing Research (NINR).
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |